Facephi Biometria (XMAD:FACE) PE Ratio without NRI: 30.45 (As of Jun. 27, 2026) — 18% Above Median


XMAD:FACE Facephi Biometria SA XMAD:FACE
70 GF Score
Price €2.04
GF Value €2.91
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Facephi Biometria PE Ratio without NRI?

Facephi Biometria XMAD:FACE -1.45% 70 PE Ratio without NRI is 30.45 as of Jun. 27, 2026, which is 18% above its 10-year median of 25.76. GuruFocus rates XMAD:FACE with a GF Score™ of 70/100 and a GF Value™ of €2.91 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,719 Software companies, Facephi Biometria ranks worse than 66.78% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-27), Facephi Biometria's share price is €2.04. Facephi Biometria's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07. Therefore, Facephi Biometria's PE Ratio without NRI for today is 30.45.

During the past 13 years, Facephi Biometria's highest PE Ratio without NRI was 57.16. The lowest was 9.10. And the median was 25.76.

Facephi Biometria's EPS without NRI for the six months ended in Dec. 2025 was €0.28. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07.

As of today (2026-06-27), Facephi Biometria's share price is €2.04. Facephi Biometria's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01. Therefore, Facephi Biometria's PE Ratio (TTM) for today is 145.71.

Good Sign:

Facephi Biometria SA stock PE Ratio (=146.43) is close to 2-year low of 142.86.

During the past years, Facephi Biometria's highest PE Ratio (TTM) was 188.57. The lowest was 9.10. And the median was 39.84.

Facephi Biometria's EPS (Diluted) for the six months ended in Dec. 2025 was €0.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.

Facephi Biometria's EPS (Basic) for the six months ended in Dec. 2025 was €0.21. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.


Facephi Biometria  (XMAD:FACE) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Facephi Biometria PE Ratio without NRI Related Terms


Facephi Biometria PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Facephi Biometria's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Facephi Biometria PE Ratio without NRI Chart

Facephi Biometria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss 19.23 At Loss At Loss 37.76

Facephi Biometria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 37.76

XMAD:FACE vs CRM, SHOP, UBER: PE Ratio without NRI Comparison

For the Software - Application subindustry, Facephi Biometria's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Facephi Biometria PE Ratio without NRI vs Software Industry

For the Software industry and Technology sector, Facephi Biometria's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Facephi Biometria's PE Ratio without NRI falls into.


XMAD:FACE
70GF Score
Facephi Biometria SA XMAD:FACE
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Facephi Biometria PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Facephi Biometria's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=2.04/0.067
=30.45

Facephi Biometria's Share Price of today is €2.04.
For company reported semi-annually, Facephi Biometria's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 30.45 mean?
Facephi Biometria (XMAD:FACE) has a PE Ratio without NRI of 30.45 as of Jun. 27, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Facephi Biometria and its competitors. This is 18% above median its historical median of 25.76. Over the past decade, Facephi Biometria's PE Ratio without NRI has ranged from 9.10 to 57.16. According to the industry distribution chart, Facephi Biometria ranks #1148 out of 1719 companies in the Software industry, placing it in the top 66.8%.
Is Facephi Biometria's PE Ratio without NRI too high?
Facephi Biometria's current PE Ratio without NRI of 30.45 is 18% above median its 10-year median of 25.76. Over the past 10 years, this metric has ranged from a low of 9.10 to a high of 57.16. The Software industry median PE Ratio without NRI is 19.72. Facephi Biometria's value of 30.45 is 54.4% above this industry median. Based on the distribution chart, Facephi Biometria ranks #1148 out of 1719 companies in the Software industry, which is below the industry midpoint. Overall, Facephi Biometria has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Facephi Biometria's PE Ratio without NRI compare to CRM and SHOP?
According to the Software industry distribution chart, Facephi Biometria ranks #1148 out of 1719 companies for PE Ratio without NRI. This places Facephi Biometria in the lower half of its industry. The industry median PE Ratio without NRI is 19.72. Facephi Biometria's value of 30.45 is 54.4% above this benchmark. Historically, Facephi Biometria's own PE Ratio without NRI has ranged from 9.10 to 57.16 over the past decade. While the company's 10-year median is 25.76 vs. the industry median of 19.72, Facephi Biometria has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Software company?
The median PE Ratio without NRI among Software companies is 19.72, based on 1,719 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Facephi Biometria's current PE Ratio without NRI of 30.45 is 54.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Facephi Biometria and its competitors. For the Software industry, the median PE Ratio without NRI is 19.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Facephi Biometria's current PE Ratio without NRI is 30.45, which is 18% above median its own 10-year median of 25.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Facephi Biometria stock overvalued right now?
Based on GuruFocus' analysis, Facephi Biometria (XMAD:FACE) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.91, compared to a current price of €2.04 — trading 29.9% below its estimated fair value. The current PE Ratio without NRI is 30.45, which is 18% above median its 10-year median of 25.76 and 54.4% above the Software industry median of 19.72. Facephi Biometria's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Facephi Biometria (XMAD:FACE), the current PE Ratio without NRI is 30.45 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Facephi Biometria (XMAD:FACE) Overvalued in 2026?

Based on GuruFocus' analysis, Facephi Biometria stock appears to be undervalued. The current stock price of €2.04 is trading 29.9% below its estimated GF Value™ of €2.91. GuruFocus considers Facephi Biometria to be Significantly Undervalued.

Key valuation signals for XMAD:FACE:

  • PE Ratio without NRI: 30.45 (18% above median its 10-year median of 25.76)
  • GF Value™: €2.91 vs. price of €2.04 (29.9% below fair value)
  • GF Score™: 70/100 with 3 warning signs
  • Industry Position: 54.4% above the Software median (#1148 of 1719)

No single metric tells the full story. See the XMAD:FACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Facephi Biometria Business Description

Other Exchanges ALPHI:France8FB:Germany
Address Avenida Perfecto Palacio de la Fuente, 6, Alicante, ESP, 03001
Facephi Biometria SA is a technology company specializing in digital identity verification, fraud prevention, and regulatory compliance solutions. It delivers an AI/ML-powered Identity & Anti-Fraud platform that provides a comprehensive 360-degree end-to-end approach to digital protection. It develops solutions that make digital processes safer, more accessible, and fraud-free. Its technologies help prevent identity theft while ensuring the ethical management and protection of personal data. Geographically, it operates in Spain and the rest of Countries with the majority of the revenue from the rest of Countries.
70GF Score

Get the complete analysis for XMAD:FACE

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.04
Price
€2.91
GF Value